Feature

Perspectives

Rationale for the Development of Clinical Pathways and an Overview of the Clinical Pathways Office at the Seattle Cancer Care Alliance

09/19/2017

Sanu Jain , BS, MHA;

Abstract: The United States health care system continues moving away from an unsustainable fee-for-service payment model to more novel measures of care delivery. Clinical pathways have emerged as one of the...

...

09/19/2017

Journal of Clinical Pathways

Perspectives

Pharmaceutical Manufacturer Responses to Health Care Professional and Clinical Pathway Developer Requests for Medical Information

08/16/2017

JR Meloro , BA;

AnnaMaria D'Ascoli , BS, PharmD, MBA;

Teresa McShane , PhD, DVM;

Abstract: Oncology is one of the most complex and rapidly changing fields in medicine. Both practicing health care professionals (HCPs) and developers of clinical pathways require information about the latest...

...

08/16/2017

Journal of Clinical Pathways

Perspectives

Accountable Health Care

06/14/2017

Anita Ballaney , MBA, MCA, BSc;

Abstract: Since its passage in 2010, the Patient Protection and Affordable Care Act (ACA) has caused widespread disruption in the US health care ecosystem. This has put a huge spotlight on the system’s shortcomings,...

...

06/14/2017

Journal of Clinical Pathways

Research Reports

The Impact of a Multidisciplinary Care Coordination Protocol On Patient-Centered Outcomes at an Academic Medical Center

05/12/2017

Amit S. Dhamoon , MD, PhD;

Chris Lau , MD;

Abstract: Effective coordination of care has been associated with improved performance on patient-centered measures of care quality. A standardized protocol for conducting multidisciplinary rounds (MDR) can improve...

...

05/12/2017

Journal of Clinical Pathways

Research Reports

Cost-Effectiveness of a Patient Navigation Program for Colorectal Cancer Screening

05/12/2017

Andrea Dwyer , BS;

R. Mark Gritz , PhD;

Yvonne Kellar-Guenther , PhD;

Whitney C. Rhodes , PhD, MSPA;

Arnold H. Levinson , PhD, MJ;

Abstract: Patient navigators (PNs) support colorectal screening through increased attendance and improved bowel preparation and are now frequently embedded in primary care settings. In order to determine whether...

...

05/12/2017

Journal of Clinical Pathways

From the Field

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplant Program

04/11/2017

Belinda R. Avalos , MD;

Abstract: The Levine Cancer Institute (LCI) of the Carolinas HealthCare System was established in Charlotte, NC, in 2010 as a primary through quaternary referral center. The Department of Hematologic Oncology and...

...

04/11/2017

Journal of Clinical Pathways

Research Reports

Length of Stay and Costs of COPD: Analysis of Hospitalized Patients Treated With Arformoterol or Nebulized Short-Acting Beta2-Agonists

04/11/2017

Tina Hunter , PhD;

Scott B. Robinson , PhD, MD;

Vamsi K. Bollu , PhD, MBA;

Krithika Rajagopalan , PhD;

Bernadette H. Johnson , MBA;

Frank R. Ernst , PharmD, MS;

Abstract: Hospitalization costs are substantial in chronic obstructive pulmonary disease (COPD). Little is known regarding the effect of long-acting beta2-agonists (LABAs) vs short-acting beta2-agonists (SABAs) on...

...

04/11/2017

Journal of Clinical Pathways

Research Reports

Clinical Pathways: A Current Snapshot, and the Journey Ahead

03/15/2017

Amy Schroeder , RPh;

03/15/2017

Journal of Clinical Pathways

Perspectives

Patient-Reported Outcome Measurement in Clinical Practice: Overcoming Challenges to Continue Progress

02/13/2017

Michele Y. Halyard , MD;

Rahma Warsame , MD;

Abstract: Health systems are evolving to make the patient the central focus of health care delivery. This has resulted in increased use and interest in patient-reported outcomes (PROs) to include the patient’s...

...

02/13/2017

Journal of Clinical Pathways

Special Article

The Solution to More Effective Diabetes Management: Better Products or Better Programs?

12/09/2016

Larry Blandford , PharmD;

Larry Blandford, PharmD, discusses the high costs of diabetes treatment and questions whether better products or better programs are the solution to more effective diabetes care.

Larry Blandford, PharmD,...

12/09/2016

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products